Skip to main content

Table 1 Demographics and clinical characteristics of study participants

From: The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study

 

All participants n = 1189

eGFR ≥ 90 n = 195

60 ≤ eGFR < 90 n = 796

eGFR < 60 n = 198

P value

Characteristics

Median (IQR) or n (%)

Median (IQR) or n (%)

Median (IQR) or n (%)

Median (IQR) or n (%)

 

Sex, female

644 (54.2)

117 (60.0)

422 (53.0)

105 (53.0)

0.202

Age, years

70.24 (64.32, 75.88)

65.21 (62.79, 69.91)

70.42 (64.68, 75.69)

75.56 (69.70, 79.83)

 < 0.001

Education, years

12.00 (9.00, 15.00)

12.0 (9.00, 15.00)

12.00 (9.00, 15.00)

12.00 (9.00, 15.00)

0.767

BMI, kg/m2

24.68 (22.55, 27.05)

24.39 (22.44, 26.56)

24.61 (22.59, 27.07)

25.39 (22.96, 27.20)

0.227

APOE ε4 carrier

202 (17.0)

31 (15.9)

140 (17.6)

31 (15.7)

0.735

Stroke

154 (13.0)

19 (9.8)

103 (12.9)

32 (16.2)

0.164

Hypertension

621 (52.2)

109 (55.9)

401 (50.4)

111 (56.1)

0.191

Diabetes

167 (14.1)

33 (16.9)

109 (13.7)

25 (12.6)

0.410

MMSE

29 (28.00, 30.00)

29.00 (28.00, 30.00)

29.00 (28.00, 30.00)

29.00 (27.00, 29.50)

0.007

Domain-specific

 Memorya

0.03 (− 0.67, 0.62)

0.24 (− 0.36, 0.73)

 − 0.05 (− 0.60, 0.62)

 − 0.11 (− 0.96, 0.41)

 < 0.001

 Visuospatial abilitya

 − 0.34 (− 0.75, 0.46)

0.06 (− 0.75, 0.46)

 − 0.34 (− 0.75, 0.56)

 − 0.34 (− 0.75, 0.46)

0.028

 Attentiona

0.016 (− 0.65, 0.56)

0.18 (− 0.40, 0.89)

 − 0.03 (− 0.68, 0.56)

 − 0.08 (− 0.94, 0.49)

 < 0.001

 Executive functiona

0.21 (− 0.23, 0.57)

0.35 (− 0.01, 0.65)

0.20 (− 0.20, 0.56)

0.08 (− 0.56, 0.49)

 < 0.001

 Languagea

0.46 (− 0.30, 0.85)

0.46 (− 0.30, 0.85)

0.46 (− 0.30, 0.85)

0.08 (− 0.68, 0.85)

0.018

 CysC (mg/l)

1.00 (0.88, 1.14)

0.79 (0.73, 0.84)

1.00 (0.93, 1.09)

1.33 (1.22, 1.46)

 < 0.001

 Creatinine (mg/dl)

0.86 (0.72, 1.01)

0.68 (0.60, 0.76)

0.85 (0.75, 0.97)

1.13 (0.98, 1.27)

 < 0.001

 Uric acid (mg/dl)

334.00 (285.50, 388.00)

295.00 (254.00, 343.00)

331.50 (286.00, 379.00)

389.00 (325.75, 452.00)

 < 0.001

 Plasma NfL (pg/ml)

15.50 (11.83, 21.38)

12.27 (9.73, 16.73)

15.50 (11.94, 20.25)

20.70 (15.17, 28.25)

 < 0.001

 Plasma P-tau181 (pg/ml)

1.91 (1.49, 2.47)

1.74 (1.39, 2.20)

1.90 (1.50,2.44)

2.17 (1.65, 2.77)

 < 0.001

 eGFR (ml/min/1.73 m2)

74.78 (64.53, 85.55)

95.93 (92.42, 100.28)

74.84 (68.79, 82.07)

52.36 (48.00, 56.00)

 < 0.001

  1. Abbreviations: APOE apolipoprotein E, BMI body mass index, MMSE Mini-Mental State Examination, NfL neurofilament light chain, P-tau181 tau phosphorylated at threonine 181, CysC cystatin C, eGFR estimated glomerular filtration rate, IQR interquartile range
  2. aZ score transformed